L&T Technology Services Ltd
Q1 FY24 Earnings Call Analysis
IT - Services
capex: Yesfundraise: No informationrevenue: Category 4margin: Category 4orderbook: No information
🏗️capex
Any current/future capex/capital investment/strategic investment?
- Company is focusing on **long-term investments** aligned with their strategy, especially in software-defined products across Industrial and Medical segments.
- Investments include **integrated digital platforms** for connected intelligent products and software-defined everything requirements.
- **Legacy plant modernization** is a continuous need and a key investment area.
- Emphasis on **Digital Twin technologies** and **Asset Healthcare solutions** for predictive-prescriptive analytics in manufacturing and plants.
- Investment in **GenAI enabled pluggable modules** for automation and smart PIDs to optimize legacy plants.
- Segment heads have identified specific investments to bootstrap growth, focusing on digital manufacturing, virtualization, and cloud-native frameworks.
- Additional investment in a **separate cell for cybersecurity**, creating common assets and IP to scale globally.
- The new organizational structure and reorganization to **"Go Deeper to Scale"** will entail **front-ended investments in people and technology** starting FY25.
- The company is exploring **M&A opportunities** in ISV, MedTech, and Auto segments, aiming for considered acquisitions that add strategic value.
📊revenue
Future growth expectations in sales/revenue/volumes?
- FY25 revenue growth guidance is 8-10% in USD constant currency, with an aspiration to reach a $1.5 billion run rate by FY25.
- Growth is expected to be back-ended in FY25 due to geopolitical uncertainties affecting decision-making in the near term.
- Positive growth drivers include:
- Mobility: Increased spend in software defined vehicles (SDV), engaging with 8 major OEMs, focusing on experience zones and ADAS.
- Sustainability: New spends in Oil & Gas, Chemicals, FMCG; growth in Digital Products, AI, and Digital Manufacturing.
- Hi-Tech: Expansion in MedTech, Semiconductors, Hyperscalers, and next-gen communications.
- Large deals closed in FY24 included 25 deals over $10M, with 1 $100M deal, indicating strong pipeline.
- Continued investment in growth segments like Mobility, Sustainability, and Hi-Tech with a streamlined organizational structure to drive client intimacy and innovation.
- Some softness expected in Q1 and Q2 margins, with recovery in H2 FY25.
📈margin
Future growth expectations in earnings/operating earnings/profits/EPS?
- LTTS expects USD constant currency revenue growth of 8-10% for FY25, with aspirations to reach a $1.5 billion annual run rate.
- EBIT margin guidance for FY25 is around 16%, slightly lower than FY24’s 17.1%, due to new investments and geopolitical uncertainties; the company aims to improve margins medium-term.
- The company aspires to return to 18% EBIT margin levels by H1 FY26 but expects it will take a few quarters to clarify this.
- Profit for FY24 was ₹1,304 crores; strong free cash flow and ROE at 27% suggest healthy profitability.
- Margin softness is attributed to investments in people, technology, and new organizational structure focused on Mobility, Sustainability, and Hi-Tech segments.
- LTTS targets organic growth of 8-10% CC and is working on M&A opportunities for medium to long-term growth acceleration.
📋orderbook
Current/ Expected Orderbook/ Pending Orders?
- The transcript does not explicitly state the current or expected order book value.
- Management highlighted a strong deal pipeline gradually building up, with large deal wins in Q4 including one $100 million, one $30 million, two $20 million, and two $10 million deals.
- A significant empanelment win was secured in the Oil & Gas sector.
- Decision-making delays due to geopolitical and economic uncertainties persist, impacting deal closures.
- The company remains optimistic about growth opportunities in Mobility, Sustainability, and Hi-Tech segments.
- Workshops and leadership elevation indicate strengthening of deal acquisition capabilities.
- M&A activity is ongoing, targeting strategic acquisitions in ISV, MedTech, North America, and Auto in Europe, which could contribute to future order growth.
- Overall, the company is confident about sustaining an 8-10% revenue growth and reaching a $1.5 billion run rate in FY25 tied to robust order inflow and pipeline.
💰fundraise
Any current/future new fundraising through debt or equity?
- The transcript does not mention any current or planned fundraising through debt or equity.
- The company focuses on strategic investments funded internally, as indicated by cash flow and investment discussions.
- Cash and investments remained robust at ₹2,883 crores after paying dividends and acquiring SWC.
- Free cash flow hit an all-time high of ₹1,251 crores in FY24, suggesting strong internal funding capability.
- Management emphasized considered acquisitions and investments but noted no hasty decisions on funding.
- No announcements or indications about raising capital via debt or equity were disclosed during this call.
